S. 1717: Ensuring Patient Access to Critical Breakthrough Products Act of 2025
A Senate bill (S.) in the 119th U.S. Congress.
Overview
| Congress | 119th U.S. Congress (2025–2026) |
|---|---|
| Type | Senate bill (S.) |
| Originating chamber | Senate |
| Introduced | 2025-05-12 |
| Sponsor | Sen. Young, Todd [R-IN] |
| Policy area | Health |
| Cosponsors | 5 |
| Latest action | 2025-05-12 — Read twice and referred to the Committee on Finance. |
| Last updated | 2026-06-11 |
Summary
An official summary for this measure has not been published by Congress. The full text is available on congress.gov.
Cosponsors (5)
| Name | Party / state |
|---|---|
| Alex Padilla | D CA (original cosponsor) 2025-05-12 |
| John Barrasso | R WY 2025-11-10 |
| Adam B. Schiff | D CA 2025-11-10 |
| Jeanne Shaheen | D NH 2026-06-10 |
| Roger Marshall | R KS 2026-06-10 |
Full text & official record
The official bill text, section-by-section summary, amendments, committee reports, and the complete legislative timeline for S. 1717 are published by Congress on congress.gov.
View S. 1717 on congress.gov →
Frequently asked questions
What is S. 1717?
S. 1717 is a Senate bill (S.) introduced in the 119th U.S. Congress, originating in the Senate. Official title: Ensuring Patient Access to Critical Breakthrough Products Act of 2025.
Where can I read the full bill text?
The full text, cosponsors, amendments, and legislative status for S. 1717 are available on congress.gov.
Bill data: congress.gov API (official congressional records).